Cerebral Venous-Sinus Thrombosis: Risk Factors, Clinical Report, and Outcome. A Prospective Study in the North East of Iran

Authors

  • Ali Ghabeli-Juibary Resident of Neurology, Student Research Committee, Department of Neurology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  • Fariborz Rezaeitalab Assistant Professor of Neurology, Department of Neurology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran ; [email protected]
  • Mohammad-Taghi Farzadfard Assistant Professor of Neurology, Department of Neurology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  • Mohsen Foroughipour Professor of Neurology, Department of Neurology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  • Siamak Yazdani Resident of Neurology, Student Research Committee, Department of Neurology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Abstract:

Introduction: Cerebral venous-sinus thrombosis (CVST) is a life threatening condition that needs rapid diagnosis and treatment. It appears comparatively more common in Middle East and South Asia. Objectives: To determine the demographic, clinical patterns, etiologies and prognostic factors of CVST in the North East of Iran. Materials and Methods: All adult patients admitted with a documented diagnosis of CVST from January 2011 to March 2012 in an academic hospital in the North East of Iran, entered this prospective descriptive study. The patients' demographic characteristics, clinical presentations, laboratory and brain imaging findings, treatment options were also studied. Follow-up visits were performed at month 1, 6, and then at month 12 using modified Rankin Scale (mRS). Findings were analyzed using descriptive tests and Chi square test in SPSS software version 21. Results: Sixty patients (13.3% men, 86.7% women) with mean age of 38.11±11.30 years were identified. Fifty one cases (85%) had a clinical picture of increased intracranial pressure. Causes included positive antiphospholipid antibodies in 3.3%, protein C, S and anti thrombin III deficiency in 5%, 1.7% and 3.3%, polycythemia in 1.7%, infections in 1.7%, postpartum in 9.6% of women, and using Oral Contraceptive Pills (OCPs) in 65.38%. We found 10% mortality rate on discharge and 11.9% within 30 days and 42.7% rate of death or dependency at month 12. Conclusion: The findings of the study indicate that the use of OCPs was a main factor associated with CVST especially in association with inherited hypercoagulable state.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

cerebral venous-sinus thrombosis: risk factors, clinical report, and outcome. a prospective study in the north east of iran

introduction: cerebral venous-sinus thrombosis (cvst) is a life threatening condition that needs rapid diagnosis and treatment. it appears comparatively more common in middle east and south asia. objectives: to determine the demographic, clinical patterns, etiologies and prognostic factors of cvst in the north east of iran. materials and methods: all adult patients admitted with a documented di...

full text

A Study of Clinical Profile, Risk Factors and Outcome in Patients of Cerebral Venous Sinus Thrombosis

Background: Cerebral venous sinus thrombosis (CVST) is an uncommon cause of stroke with extremely varied clinical features, predisposing factors and outcomes. With the widespread use of neuroimaging and hematological work up more and more patients are being confidently diagnosed. Objective: To study the clinical profile, risk factors, radiological findings and outcome in patients of CVST at ter...

full text

Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients. For The Cerebral Venous Sinus Thrombosis Study Group.

The prognosis of cerebral venous sinus thrombosis (CVST) is variable, and outcome may range from complete recovery to death. Prognostic factors to predict outcome in the acute phase of CVST have not been analysed in a prospective study. Prognostic factors in patients enrolled in a clinical treatment trial were prospectively investigated. Poor outcome after 12 weeks, defined as death or dependen...

full text

Cerebral Venous-Sinus Thrombosis: A Case Series Analysis

Background: Cerebral venous-sinus thrombosis is an uncommon form but important cause of stroke, especially in young-aged women. Methods: We performed a retrospective descriptive-analytical study in which 124 patients with cerebral venous-sinus thrombosis, who referred to Nemazee Hospital, Shiraz University of Medical Sciences from January 2000 to March 2008, were included, and their dem...

full text

Evaluation of cerebral venous thrombosis risk following oral contraceptive use: A case report and update.

Background and Objectives: The aim of the present study was to report a case of cerebral venous thrombosis (CVT) folowing consumption of the oral contraceptive pills with high estrogen levels. Case Report: A 35-year-old woman presenting a headache was diagnosed with thrombosis in the upper sagittal, sigmoid and transverse  veins, by CT SCAN, MRI and MRV of the brain. Conclusion: The chance ...

full text

Perinatal Mortality and Its Associated Risk Factors: A Study in the North-East of Iran

Background: Perinatal mortality rate is an important indicator of community health status. This study aimed to evaluate perinatal mortality and its determinants in Mobini Hospital of Sabzevar, Iran. Methods: This descriptive, cross-sectional study was performed within a two-year (2011-2012) period at Mobini Hospital of Sabzevar. Our study population included all the cases of stillbirth and liv...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 1  issue 3

pages  27- 32

publication date 2015-10

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023